These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23355475)

  • 1. The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India.
    Olaku O; Zia F; Santana JM; White JD
    Integr Cancer Ther; 2013 Sep; 12(5):385-92. PubMed ID: 23355475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the best case series methodology: best case series results of East-West Cancer Center.
    Yoo HS; Cho CK; Hong MS
    Integr Cancer Ther; 2008 Sep; 7(3):182-8. PubMed ID: 18815149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA.
    Banerji P; Campbell DR; Banerji P
    Oncol Rep; 2008 Jul; 20(1):69-74. PubMed ID: 18575720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
    Lee CO
    Clin J Oncol Nurs; 2004 Apr; 8(2):212-4. PubMed ID: 15108425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review.
    Jacobson JS; Grann VR; Gnatt MA; Hibshoosh H; Austin JH; Millar WS; Neugut AI
    Integr Cancer Ther; 2005 Jun; 4(2):156-67. PubMed ID: 15911928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD
    Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the best case series to evaluate complementary and alternative therapies for cancer: a systematic review.
    Nahin RL
    Semin Oncol; 2002 Dec; 29(6):552-62. PubMed ID: 12516038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of complementary/alternative medicine for the treatment of asthma in the United States.
    Davis PA; Gold EB; Hackman RM; Stern JS; Gershwin ME
    J Investig Allergol Clin Immunol; 1998; 8(2):73-7. PubMed ID: 9615298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic Registration in Complementary/Homeopathic Medical Practice with Identification of 'Best Homeopathic Cases': A Pilot Study.
    Klein-Laansma CT; Rutten ALB; Fruijtier PC; Wijtenburg HHM
    Homeopathy; 2019 Feb; 108(1):33-42. PubMed ID: 30290378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery.
    Paulson EC; Mitra N; Sonnad S; Armstrong K; Wirtalla C; Kelz RR; Mahmoud NN
    Ann Surg; 2008 Oct; 248(4):675-86. PubMed ID: 18936581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine for pediatric otitis media.
    Levi JR; Brody RM; McKee-Cole K; Pribitkin E; O'Reilly R
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):926-31. PubMed ID: 23562352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Cancer Institute Best Case Series program.
    Zia FZ; White JD
    Integr Cancer Ther; 2009 Jun; 8(2):113-4. PubMed ID: 19691176
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of distress symptoms and use of complementary medicine among patients with cancer.
    Ku CF; Koo M
    J Clin Nurs; 2012 Mar; 21(5-6):736-44. PubMed ID: 22066670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitude of conventional and CAM physicians toward CAM in India.
    Telles S; Gaur V; Sharma S; Balkrishna A
    J Altern Complement Med; 2011 Nov; 17(11):1069-73. PubMed ID: 22070443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of use of complementary/alternative medicine (CAM) in epileptic patients in a tertiary care hospital in India.
    Tandon M; Prabhakar S; Pandhi P
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):457-63. PubMed ID: 12426930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of outcomes at alternative medicine cancer clinics: a feasibility study.
    Richardson MA; Russell NC; Sanders T; Barrett R; Salveson C
    J Altern Complement Med; 2001 Feb; 7(1):19-32. PubMed ID: 11246933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.
    Aydin Avci I; Koç Z; Sağlam Z
    J Clin Nurs; 2012 Mar; 21(5-6):677-88. PubMed ID: 21714820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.